Publicaciones en colaboración con investigadores/as de Radboud University Nijmegen Medical Centre (13)

2024

  1. Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network

    Arthritis and Rheumatology, Vol. 76, Núm. 4, pp. 587-598

2021

  1. A genome-wide association study of severe asthma exacerbations in Latino children and adolescents

    The European respiratory journal, Vol. 57, Núm. 4

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients

    Kidney International, Vol. 99, Núm. 3, pp. 671-685

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

2017

  1. Association between telomere length and risk of cancer and non-neoplastic diseases a mendelian randomization study

    JAMA Oncology, Vol. 3, Núm. 5, pp. 636-651

  2. Biodegradable PCL/fibroin/hydroxyapatite porous scaffolds prepared by supercritical foaming for bone regeneration

    International Journal of Pharmaceutics, Vol. 527, Núm. 1-2, pp. 115-125

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis

    Annals of the Rheumatic Diseases

2009

  1. An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 9, pp. 1433-1439